Aktive Positionen von Thomas Olson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Acesis BioMed US, Inc.
 Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | Geschäftsführer | - | - |
Acesis Holdings Corp.
 Acesis Holdings Corp. BiotechnologyHealth Technology Acesis Holdings Corp. functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders. The company was founded on October 3, 2022 and is headquartered in Lone Tree, CO. | Geschäftsführer | 03.10.2022 | - |
| Unternehmenssekretär | 03.10.2022 | - | |
| Cresthill Associates, LLC | Corporate Officer/Principal | - | - |
Karriereverlauf von Thomas Olson
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Chief Operating Officer | 2 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Acesis BioMed US, Inc.
Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | Health Technology |
Acesis Holdings Corp.
Acesis Holdings Corp. BiotechnologyHealth Technology Acesis Holdings Corp. functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders. The company was founded on October 3, 2022 and is headquartered in Lone Tree, CO. | Health Technology |
| Cresthill Associates, LLC |
- Börse
- Insiders
- Thomas Olson
- Erfahrung
